학술논문
ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
Document Type
Article
Author
Jackson, E.R.; Duchatel, R.J.; Staudt, D.E.; Persson, M.L.; Mannan, A.; Kearney, P.S.; Douglas, A.M.; Findlay, I.J.; Germon, Z.P.; McEwen, H.P.; Beitaki, T.S.; Dun, M.D.; Alvaro, F.; Yadavilli, S.; Nazarian, J.; Parackal, S.; Game, S.; Chong, W.C.; Jayasekara, W.N.S.; Firestein, R.; Cain, J.E.; Le Grand, M.; Pasquier, E.; André, N.; Patabendige, A.; Skerrett-Byrne, D.A.; Nixon, B.; Smith, N.D.; Day, B.; Manoharan, N.; Nagabushan, S.; Hansford, J.R.; Govender, D.; McCowage, G.B.; Howlett, M.; Endersby, R.; Gottardo, N.G.; Waszak, S.M.; Larsen, M.R.; Colino-Sanguino, Y.; Valdes-Mora, F.; Rakotomalala, A.; Meignan, S.; Hulleman, E.; Eisenstat, D.D.; Vitanza, N.A.; Mueller, S.; Koschmann, C.
Source
In: Cancer Research . (Cancer Research, July 2023, 83(14):2421-2437)
Subject
Language
English
ISSN
15387445
00085472
00085472